A possible role for the alpha 1 → 3 galactosyl epitope and the natural anti-gal antibody in oncogenesis

Neoplasma

Volumn 43, Issue 5, 1996, Pages 285-289

  Gollogly, L ^a   Castronovo, V ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

antibodies; glycoconjugates; oncogenesis

Indexed keywords

ALPHA 1,3 GALACTOSYL; EPITOPE; GLYCOCONJUGATE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; HUMAN;

EID: 0029857352     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. AVILA, J.R., M. GALILI, U.: Immunogenic gal 1-3 gal carbohydrate epitopes are present on pathogenic American trypanosoma and leishmania. J. Immunol., 142, 1989, 2828-2834.
2. BORREBAECK, C.M., A.C., OHLIN, M.: Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics? Immunol. Today, 14, 1993, 477-479.
3. CASTRONOVO, V., COLIN, C., PARENT, B., FOIDART, J.M., LAMBOTTE, R., MAHIEU, P.: Possible role of human natural anti-Gal antibodies in the natural antitumor defense system. J. Natl. Cancer Inst., 81, 1989, 212-215.
4. CASTRONOVO, V.F., J.M., VECCHI, M.L., FOIDART, J.B., BRACKE, M., MAREEL, M., MAHIEU, P.: Human anti-alpha-galactosyl IgG reduces the lung colonization by murine MO4 cells. Invasion Metastasis, 7, 1987, 325-345.
5. CHEN, Y.F., BOLAND, C.R., KRAUS, E.R., GOLDSTEIN, I.J.: The lectin Griffonia simplicifolia I-A4 (GS I-A4) specifically recognizes terminal alpha-linked N-acetylgalactosaminyl groups and is cytotoxic to the human colon cancer cell lines LS174t and SW1116. Int. J. Cancer, 57, 1994, 561-567.
6. COCHRAN, A.J., BERTHIER, V.O., ZEDBA, N., BAILLY, M., THOMAS, L., BAILLY, C., DORE, J.F.: Glycoconjugate alterations in malignant melanoma reflect metastatic potential. Meeting abstract. Proc. Annu. Meet. Am. Assoc. Cancer Res., 1993, A372, 1993.
7. GALILI, U., KORKESH, A., KAHANE, I., RACHMILEWITZ, E.: Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood, 61, 1983, 1258-1264.
8. GALILI, U., BUEHLER, J., SHOHET, S., MACHER, B.: The human natural anti-gal IgG the subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-gal and anti-B antibodies. J. Exp. Med., 165, 1987, 693-704.
9. GALILI, U.: Abnormal expression of alpha galactosyl epitopes in man. Lancet, 2, 1989, 358-360.
10. GALILI, U.: Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol. Today, 14, 1993, 480-482.
11. GALILI, U.B., C., SHOHET, S., BUEHLER, J., MACHER, B.: Identification of erythrocyte gal 1-3 gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. J. Biol. Chem., 262, 1987, 4683-4688.
12. GALILI, U.M., R., HAMADEH, R., SHOHET, S., GRIFFISS, J.: Interaction between human natural anti-alpha galactosyl immunoglobulin G and bacteria of the human flora Infect. Immunol., 1988, 1730-1736.
13. GAZZINELLI, R.T.: Natural anti-Gal antibodies prevent, rather than cause, autoimmunity in human Chagas' disease. Res. Immunol., 142, 1991, 164-167.
14. GORELIK, E.D., L., ANARAKI, F., GALILI, U.: Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection. Cancer Res., 55, 1995, 4168-4173.
15. HAKOMORI, S.: Aberrant glycosylation in cancer cell membranes as focused on glycolipids. Cancer Res., 45, 1985, 2405-2414.
16. KAGAWA, Y.T., S., UTSUMI, J., HOSOI, K., SHIMIZU, H., KOCHIBE, N., KOBATA, A.: Comparative study of the aspargine-linked sugar chains of natural human interferon-1 and recombinant human interferon produced by three different mammalian cells. J. Biol. Chem., 263, 1988, 17 508-17 515.
17. KAWAGUCHI, T., ONO, T., WAKABAYASHI, H., IGARASHI, S.: Cell surface laminin-like substances and laminin-related carbohydrates of rat ascites hepatoma AH7974 and its variants with different lung-colonizing potential. Clin. Exp. Metastasis, 12, 1994, 203-212.
18. KORNFELD, R.K., S.: Assembly of asparagine-linked oligosaccharides. Ann. Rev. Biochem., 50, 1985, 555-583.
19. LARSEN, R.D., RIVERA-MARRERO, C.A., ERNST, L.K., CUMMINGS, R.D., LOWE, J.B.: Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-gal: Galactosyltransferase c DNA. J. Biol. Chem., 265, 1990, 7055-7061.
20. SANDRIN, M.S., FODOR, W.L., MOUHTOURIS, E., OSMAN, N., COHNEY, S., ROLLINS, S.A., GUILMETTE, E.R., SETTER, E., SQUINTO, S., MCKENZIE, I.: Enzymatic remodelling of the carbohydrate of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat. Med., 1, 1995, 1261-1267.
21. SHAPER, N.L., S., JOZIASSE, D., KIM, D., YANG-FENG, T.: Assignment of two human 1,3-galactosyltransferase gene sequences (GGTA1 and GGTA1P) to chromosomes 9q33-q34 and 12q14-q15. Genomics, 12, 1992, 613-615.
22. SHARON, N.L., H.: Glycoproteins: Research booming on long-ignored, ubiquitous compounds. Mol. Cell. Biochem., 42, 1982, 167-187.
23. THALL, A., ETIENNE-DECERF, J., WINAND, R., GALILI, U.: The alpha galactosyl epitope on mammalian thyroid cells. Acta Endocrinol., 124, 1991, 692-699.
24. TOWBIN, H., ROSENFELDER, G., WIESLANDER, J., AVILA, J., ROJAS, M., SZARFMAN, A., ESSER, D., NOWACK, H., TIMPL, R.: Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl (1-3)-galactosyl epitopes. J. Exp. Med., 166, 1987, 419-432.
25. WINAND, R., ANARAKI, F., ETIENNE-DECERF, J., GALILI, U.: Xenogenic thyroid-stimulating hormone-like activity of the human natural anti-gal-antibody. J. Immunol., 151, 1993, 3923-3934.
26. WINAND, R., DEVIGNE, J., MEURISSE, M., GALILI, U.: Specific stimulation of Graves' disease thyrocytes by the natural anti-gal antibody from normal and autologous serum. J. Immunol., 22, 1994, 1386-1395.
27. YOGEESWARWN, G., SALK, P.L.: Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumour lines. Science, 212, 1981, 1514-1516.